Experience with ospemifene in patients with vulvar and vaginal atrophy: case studies with bone marker profiles

Experience with ospemifene in patients with vulvar and vaginal atrophy: case studies with bone marker profiles

Selective estrogen receptor modulators (SERMs) exhibit varying agonist/antagonist activities on estrogen receptors in tissues, although most SERMs, including ospemifene, have agonist effects on bone. In this article, outcomes in relation to bone homeostasis, bone mineral density (BMD), and osteopeni...

Full description

Bibliographic Details
Main Authors: María del Carmen Pingarrón Santofimia, Silvia Pilar González Rodríguez, Mariella Lilue, Santiago Palacios
Format: Article
Language:English
Published: BioExcel Publishing Ltd 2020-07-01
Series:Drugs in Context
Subjects:
bone biomarkers
bone homeostasis
ospemifene
vulvar and vaginal atrophy
Online Access:https://www.drugsincontext.com/experience-with-ospemifene-in-patients-with-vulvar-and-vaginal-atrophy:-case-studies-with-bone-marker-profiles/

Internet

https://www.drugsincontext.com/experience-with-ospemifene-in-patients-with-vulvar-and-vaginal-atrophy:-case-studies-with-bone-marker-profiles/

Similar Items